For over a decade, industry watchdogs, patient groups and various lawmakers have been calling for drug pricing reform—initially with...
A Fresh Take
Insights on M&A, litigation, and corporate governance in the US.
We're pleased to announce Freshfields' 2022 De-SPAC Debrief: A comprehensive review of all 102 de-SPAC transactions that closed in 2022....
On Monday, the Supreme Court dismissed as improvidently granted the writ of certiorari of In re Grand Jury, a case about the scope of...
/Passle/5e8c58ad3dccd208784b45a3/MediaLibrary/Images/5e7cb459342a4f03803cef70/2020-11-19-17-28-20-832-5fb6ab34e5416a0eb07cb3a6.png)
On January 23, 2023, the US Federal Trade Commission (FTC) announced its annual updates to the Hart-Scott-Rodino (HSR) Act reportability...
The 41st Annual J.P. Morgan Healthcare Conference, held in-person for the first time in three years, was a tale of two cities – marked...
Earlier this week, the Supreme Court heard oral argument in In re Grand Jury, a case you may not have heard much about, but one that may...
The US Federal Trade Commission (“FTC”) is following through on its commitment to more closely police competition issues in labor...
Tension between institutional shareholders and boards about strategic alternatives . We are emerging from several consecutive years...